Spain boosts organ transplant, raises alarm over EU needs
This article was originally published in Clinica
Plans are underway to reform and strengthen Spain's National Transplant Organisation (ONT) as the country's pre-eminent centre for the transplant of organs, tissues and cells, health minister Elena Salgado has announced. Although the centre's stem cell research activities are to go to the Instituto de Salud Carlos III, the ONT will retain its role as national co-ordinator of the clinical applications of "cell therapy".
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.